Li Hongjun

Associate Director at Transcenta - N/A, N/A, N/A

Li Hongjun's Colleagues at Transcenta
Liu Tie

Executive Director, Analytical Science

Contact Liu Tie

John Huang

Sr. Director, Clinical SAS Programming

Contact John Huang

Yingjie Huang

SVP, Clinical Development and Regulatory Affair

Contact Yingjie Huang

View All Li Hongjun's Colleagues
Li Hongjun's Contact Details
HQ
N/A
Location
Suzhou,Jiangsu,China
Company
Transcenta
Li Hongjun's Company Details
Transcenta logo, Transcenta contact details

Transcenta

N/A, N/A, N/A • 250 - 499 Employees
Major Drugs

Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628.Transcenta has established global footprint, with Headquarters and Discovery, Clinical and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston and Los Angeles, US. Transcenta is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. For more information, please visit www.transcenta.com.

N/A
Details about Transcenta
Frequently Asked Questions about Li Hongjun
Li Hongjun currently works for Transcenta.
Li Hongjun's role at Transcenta is Associate Director.
Li Hongjun's email address is ***@transcenta.com. To view Li Hongjun's full email address, please signup to ConnectPlex.
Li Hongjun works in the Pharmaceuticals industry.
Li Hongjun's colleagues at Transcenta are Suzanne Stevenson, Jianming Wang, Liu Tie, Xichen Zhang, Paris Tang, John Huang, Yingjie Huang and others.
Li Hongjun's phone number is N/A
See more information about Li Hongjun